SCHEMBL3933422

SCHEMBL3933422

CC(C)(C)OC(=O)NC(=O)N1CCC(C(=O)OCc2ccccc2)CC1

nearest known ligand 0.53

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MAPT P10636 1/20 0.53
SMN1; SMN2 Q16637 3/20 0.50
NPC1 O15118 2/20 0.50
RAB9A P51151 2/20 0.50
CTSL P07711 1/20 0.50
HTT P42858 1/20 0.49
STS P08842 1/20 0.48
CYP2C19 P33261 1/20 0.48
KMT2A Q03164 4/20 0.47
ALDH1A1 P00352 2/20 0.47
TSHR P16473 2/20 0.47
MEN1 O00255 2/20 0.47
FKBP1A P62942 2/20 0.47
GAA P10253 1/20 0.46
MAPK1 P28482 1/20 0.45
KDM4E B2RXH2 1/20 0.44
NPSR1 Q6W5P4 1/20 0.44
POLB P06746 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2374261 0.85 SMN1; SMN2 (0.62) SMN1; SMN2NPC1RAB9AHTTSTS
SCHEMBL606732 0.84 CTSL (0.52) MAPTSMN1; SMN2NPC1RAB9ACTSL
SCHEMBL951309 0.81 STS (0.56) SMN1; SMN2NPC1RAB9ACTSLHTT
SCHEMBL9038044 0.81 STS (0.56) SMN1; SMN2NPC1RAB9ACTSLHTT
SCHEMBL15626861 0.81 STS (0.56) SMN1; SMN2NPC1RAB9ACTSLHTT
SCHEMBL24897136 0.81 DRD2 (0.53) CTSLKMT2AALDH1A1TSHRMEN1
SCHEMBL2455884 0.80 SMN1; SMN2 (0.70) SMN1; SMN2NPC1RAB9AHTTSTS
SCHEMBL24131665 0.79 ALDH1A1 (0.63) CTSLKMT2AALDH1A1TSHRMEN1
SCHEMBL25431020 0.79 SIGMAR1 (0.56) MAPTCTSL
SCHEMBL20481159 0.78 SMN1; SMN2 (0.47) SMN1; SMN2NPC1RAB9ACTSLHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009010480-A1 1-{2-[(DIPHENYL)AMINO]-ETHYL}-PIPERIDINE-4-CARBOXYLIC ACID BENZYLAMIDE DERIVATIVES AND RELATED COMPOUNDS AS CCR5 AGONISTS FOR THE TREATMENT OF IMMUNE AND INFLAMMATORY DISEASES EUROSCREEN S.A. (BE) 2009-01-22 WO disclosed